MYND Life Sciences (XCNQ:MYND) Receivables Turnover : 0.00 (As of Jul. 2024)

View and export this data going back to 2021. Start your Free Trial

What is MYND Life Sciences Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. MYND Life Sciences's Revenue for the three months ended in Jul. 2024 was C$0.00 Mil. MYND Life Sciences's average Accounts Receivable for the three months ended in Jul. 2024 was C$0.65 Mil.

MYND Life Sciences Receivables Turnover Historical Data

The historical data trend for MYND Life Sciences's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MYND Life Sciences Receivables Turnover Chart

MYND Life Sciences Annual Data

Trend

Oct21

Oct22

Oct23

Receivables Turnover

MYND Life Sciences Quarterly Data
	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Receivables Turnover	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of MYND Life Sciences's Receivables Turnover

For the Biotechnology subindustry, MYND Life Sciences's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MYND Life Sciences's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MYND Life Sciences's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where MYND Life Sciences's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

MYND Life Sciences Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

MYND Life Sciences's Receivables Turnover for the fiscal year that ended in Oct. 2023 is calculated as

	Receivables Turnover (A: Oct. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Oct. 2023 )	/ (	(Accounts Receivable (A: Oct. 2022 )	+	Accounts Receivable (A: Oct. 2023 ))	/	count )
=	0	/ (	(0	+	0.777)	/	1 )
=	0	/	0.777
=	N/A

MYND Life Sciences's Receivables Turnover for the quarter that ended in Jul. 2024 is calculated as

	Receivables Turnover (Q: Jul. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Jul. 2024 )	/ (	(Accounts Receivable (Q: Apr. 2024 )	+	Accounts Receivable (Q: Jul. 2024 ))	/	count )
=	0	/ (	(0.69	+	0.604)	/	2 )
=	0	/	0.647
=	N/A

MYND Life Sciences (XCNQ:MYND) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

MYND Life Sciences Receivables Turnover Related Terms

Thank you for viewing the detailed overview of MYND Life Sciences's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

MYND Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MYND Life Sciences Inc (XCNQ:MYND) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

MYNDF:USA

Address

105-2248 Elgin Avenue, Port Coquitlam, BC, CAN, V3C 2B2

Website

https://www.myndsciences.com

MYND Life Sciences Inc is a medical biotech drug research and development company. The company is focused on neuro pharmaceutical and novel drug development, diagnostics, and vaccines and is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by different molecular concepts for the applications of psilocybin analogs for overcoming diseases.